awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50921086-273D9557-B6C8-48B5-8FFD-3F64F13326EB
Q50921086-273D9557-B6C8-48B5-8FFD-3F64F13326EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50921086-273D9557-B6C8-48B5-8FFD-3F64F13326EB
Human MAP Tau Based Targeted Cytolytic Fusion Proteins.
P2860
Q50921086-273D9557-B6C8-48B5-8FFD-3F64F13326EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50921086-273D9557-B6C8-48B5-8FFD-3F64F13326EB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b81682b90970fadb2c9f1c87f3cd227235eb0ce8
P2860
U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma.